1. |
Borazanci E, Dang CV, Robey RW, et al. Pancreatic cancer: “A Riddle Wrapped in a Mystery inside an Enigma”. Clin Cancer Res, 2017, 23(7): 1629-1637.
|
2. |
Kamisawa T, Wood LD, Itoi T, et al. Pancreatic cancer. Lancet, 2016, 388(10039): 73-85.
|
3. |
Raufi AG, Manji GA, Chabot JA, et al. Neoadjuvant treatment for pancreatic cancer. Semin Oncol, 2019, 46(1): 19-27.
|
4. |
Singhi AD, Koay EJ, Chari ST, et al. Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology, 2019, 156(7): 2024-2040.
|
5. |
Strobel O, Neoptolemos J, Jäger D, et al. Optimizing the outcomes of pancreatic cancer surgery. Nat Rev Clin Oncol, 2019, 16(1): 11-26.
|
6. |
Kleger A, Perkhofer L, Seufferlein T. Smarter drugs emerging in pancreatic cancer therapy. Ann Oncol, 2014, 25(7): 1260-1270.
|
7. |
Unger FT, Witte I, David KA. Prediction of individual response to anticancer therapy: historical and future perspectives. Cell Mol Life Sci, 2015, 72(4): 729-757.
|
8. |
No authors listed. China plans large center for PDX models. Cancer Discov, 2014, 4(2): 136-137.
|
9. |
Hwang CI, Boj SF, Clevers H, et al. Preclinical models of pancreatic ductal adenocarcinoma. J Pathol, 2016, 238(2): 197-204.
|
10. |
Aparicio S, Hidalgo M, Kung AL. Examining the utility of patient-derived xenograft mouse models. Nat Rev Cancer, 2015, 15(5): 311-316.
|
11. |
Ehrenberg KR, Gao J, Oppel F, et al. Systematic generation of patient-derived tumor models in pancreatic cancer. Cells, 2019, 8(2): pii: E142.
|
12. |
宋书铮, 俞继卫. 癌相关成纤维细胞及其在胃肠道肿瘤演进中的作用. 中国普外基础与临床杂志, 2014, 21(10): 1311-1315.
|
13. |
Richards KE, Zeleniak AE, Fishel ML, et al. Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells. Oncogene, 2017, 36(13): 1770-1778.
|
14. |
Hessmann E, Patzak MS, Klein L, et al. Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer. Gut, 2018, 67(3): 497-507.
|
15. |
von Ahrens D, Bhagat TD, Nagrath D, et al. The role of stromal cancer-associated fibroblasts in pancreatic cancer. J Hematol Oncol, 2017, 10(1): 76.
|
16. |
Thomas D, Radhakrishnan P. Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis. Mol Cancer, 2019, 18(1): 14.
|
17. |
Lee J, Yakubov B, Ivan C, et al. Tissue transglutaminase activates cancer-associated fibroblasts and contributes to gemcitabine resistance in pancreatic cancer. Neoplasia, 2016, 18(11): 689-698.
|
18. |
Murata T, Mekada E, Hoffman RM. Reconstitution of a metastatic-resistant tumor microenvironment with cancer-associated fibroblasts enables metastasis. Cell Cycle, 2017, 16(6): 533-535.
|
19. |
Paulson AS, Tran Cao HS, Tempero MA, et al. Therapeutic advances in pancreatic cancer. Gastroenterology, 2013, 144(6): 1316-1326.
|
20. |
Henriksen A, Dyhl-Polk A, Chen I, et al. Checkpoint inhibitors in pancreatic cancer. Cancer Treat Rev, 2019, 78: 17-30.
|
21. |
Gao D, Chen Y. Organoid development in cancer genome discovery. Curr Opin Genet Dev, 2015, 30: 42-48.
|
22. |
Cantrell MA, Kuo CJ. Organoid modeling for cancer precision medicine. Genome Med, 2015, 7(1): 32.
|
23. |
Knudsen ES, Balaji U, Mannakee B, et al. Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility. Gut, 2018, 67(3): 508-520.
|
24. |
Gao D, Vela I, Sboner A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cel, 2014, 159(1): 176-187.
|
25. |
Boj SF, Hwang CI, Baker LA, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell, 2015, 160(1-2): 324-338.
|
26. |
Unger C, Kramer N, Walzl A, et al. Modeling human carcinomas: physiologically relevant 3D models to improve anti-cancer drug development. Adv Drug Deliv Rev, 2014, 79-80: 50-67.
|
27. |
李程, 陈拥华, 麦刚, 等. 精准医疗时代胰腺癌个体化类器官研究现状与应用前景. 中国普外基础与临床杂志, 2016, 23(10): 1272-1275.
|
28. |
Hohwieler M, Müller M, Frappart PO, et al. Pancreatic progenitors and organoids as a prerequisite to model pancreatic diseases and cancer. Stem Cells Int, 2019, 2019: 9301382.
|
29. |
Clevers H, Bender E. Q&A: Hans Clevers. Banking on organoids. Nature, 2015, 521(7551): S15.
|
30. |
D’Agosto S, Andreani S, Scarpa A, et al. Preclinical modelling of PDA: Is organoid the new black? Int J Mol Sci, 2019, 20(11): pii: E2766.
|
31. |
Vennin C, Murphy KJ, Morton JP, et al. Reshaping the tumor stroma for treatment of pancreatic cancer. Gastroenterology, 2018, 154(4): 820-838.
|
32. |
Nicolle R, Blum Y, Marisa L, et al. Pancreatic adenocarcinoma therapeutic targets revealed by tumor-stroma cross-talk analyses in patient-derived xenografts. Cell Rep, 2017, 21(9): 2458-2470.
|
33. |
Huang L, Holtzinger A, Jagan I, et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med, 2015, 21(11): 1364-1371.
|
34. |
董丽华, 傅士龙, 韩素萍. 人上皮性卵巢癌组织中肿瘤相关成纤维细胞的培养. 南京医科大学学报(自然科学版), 2011, 31(7): 935-939.
|
35. |
彭巍, 徐小慧, 季江, 等. 大肠癌肿瘤相关成纤维细胞原代培养方法的优化. 中华实验外科杂志, 2013, 30(5): 954-957.
|